The Long and Winding Road of Cannabis Rescheduling Is About to End 

* No more detours!

Here is the judge’s order and his decision on not reopening the rescheduling hearing:  

dea-judge-order.pdf

From Marijuana Moment:

DEA Judge Denies Marijuana Rescheduling Opponents’ Request To Reopen Hearing For More Testimony, But Allows New Briefs – Marijuana Moment

Here is The Dales Report’s summary:

In terms of timing, this likely represents a FINAL delay of the rescheduling process and will probably  lead to the judge’s recommendation in November:

“The parties are not being required to file any briefs on the matter, but are invited to submit initial filings by October 29 and any replies by November 5.” (Source: TDR)

Considering the lengthy time that cannabis investors have waited for a rescheduling decision this is not too punitive and will likely put a conclusion on the process shortly.

I am adding to $MSOS on the weakness.

Position: Long MSOS common (VL) and calls (VS) 

Clowns to the Left of Me, Jokers to the Right 

Thus far today about 25 people were asked (on Fin TV) why Meta’s ($META) shares are trading much lower in the face of better results and strong forward guidance.

No one has clearly answered the question — just a bunch of B.S. and narratives (miles long but only inches deep).

From my perch these are the principal problems facing Meta, which help to explain the market’s reaction (stated simply):

* Meta disclosed the need for continued and large capital expenditures.

* Nonetheless, the company was uncertain of the timing and whether that AI spend would be monetized and whether the ROIC would be adequate relative to the spend.

* Meta’s balance sheet is debt laden with over $100 billion of balance sheet debt and over $700 billion off balance sheet.

* As a result, to fund the big AI capex, several hundred billions of dollars in equity has to be raised by the company.

We anticipated this need for a large raise — from yesterday: 

Guesswork Only

My instincts tell me META beats consensus and offers good guidance.

And then it announces a primary offering of stock…

Position: None 

BY Doug Kass · Oct 21, 2026, 3:30 PM EDT

From Ed Zitron following the EPS release:

Position: None

Subscriber Comment of the Day

Asaxelrod

I do not have any informed opinion on IQV but Josh Brown pitches every idea with such confidence because of charts and clearly doesn’t know much fundamentally. With IQV he says “I think it’s around a $25-26B market cap” when in fact it’s ~$46B! Okay one can make mistakes but as Doug reinforces so effectively the BS on CNBC is so cheerleader-oriented everyday with such little depth. I’ve managed money for nearly three decades and humility is key in this humbling business. I don’t think anyone on the Halftime Show embraces humility but they are all exceptionally gifted at promotional hype to gather assets.  When (not IF) we have another 2022 (or perhaps 2000), I will look forward to witnessing some humility from the panelists but the expectation bar is low…

Position: None

Those Machines and Algos

I have spoken to several institutional desks.

The buying/strength is being exacerbated by machines and algos — in a changed market structure.

And I am using them as a source of liquidity — reducing $PG, $KO and $KMB.

Position: Long PG (VS), KO (VS), KMB (VS) 

Cannabis Tweet of the Day

Position: None